Precigen (PGEN) Change in Accured Expenses (2012 - 2026)
Precigen (PGEN) posted quarterly Change in Accured Expenses of -$2.3 million for Q1 2026, down 288.7% year-over-year from $1.2 million in Q1 2025, and down 977.22% quarter-over-quarter from $259000.0 in Q4 2025.
Analysis
Precigen (PGEN) Change in Accured Expenses (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Change in Accured Expenses for 15 consecutive years, with -$2.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 288.7% year-over-year to -$2.3 million; the TTM figure through Mar 2026 stood at $3.4 million (down 24.18% YoY), while the FY2025 annual figure was $6.9 million, up 118.41% from the prior year.
- Change in Accured Expenses fell to -$2.3 million in Q1 2026 per PGEN's latest filing, from $259000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $5.4 million in Q3 2023 and bottomed at -$2.8 million in Q4 2023.
- Historically, Change in Accured Expenses has averaged $412176.5 across 5 years, with a median of -$126000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 366.01% — and 2024, when it surged 1214.69%.
- Precigen's Change in Accured Expenses stood at -$939000.0 in 2022, then slumped by 202.24% to -$2.8 million in 2023, then jumped by 163.67% to $1.8 million in 2024, then slumped by 85.67% to $259000.0 in 2025, then sank by 977.22% to -$2.3 million in 2026.
- Business Quant data shows PGEN's Change in Accured Expenses at -$2.3 million in Q1 2026, $259000.0 in Q4 2025, and $1.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | 7.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.53 Mn |
| Mar 31, 2026 | -2.27 Mn |
| Dec 31, 2025 | 240,000.00 |
| Sep 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 4.57 Mn |
| Sep 30, 2024 | -2.89 Mn |
| Jun 30, 2024 | -254,000.00 |
| Mar 31, 2024 | 1.72 Mn |
| Dec 31, 2023 | 1.61 Mn |
| Sep 30, 2023 | 1.82 Mn |
| Jun 30, 2023 | -132,000.00 |
| Mar 31, 2023 | 1.94 Mn |
| Dec 31, 2022 | -939,000.00 |
| Sep 30, 2022 | -2.44 Mn |
| Jun 30, 2022 | 5.32 Mn |
| Mar 31, 2022 | -3.46 Mn |
| Dec 31, 2021 | 1.35 Mn |
| Sep 30, 2021 | 692,000.00 |